These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2018555)

  • 21. Dextromethorphan O-demethylation polymorphism in Jordanians.
    Irshaid YM; al-Hadidi HF; Rawashdeh NM
    Eur J Clin Pharmacol; 1993; 45(3):271-3. PubMed ID: 8276053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative contribution to dextromethorphan metabolism by cytochrome P450 isoforms in vitro: can dextromethorphan be used as a dual probe for both CTP2D6 and CYP3A activities?
    Yu A; Haining RL
    Drug Metab Dispos; 2001 Nov; 29(11):1514-20. PubMed ID: 11602530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vivo and in-vitro dextromethorphan metabolism in SD and DA rat. An animal model of the debrisoquine-type polymorphic oxidation in man.
    Zysset T; Zeugin T; Küpfer A
    Biochem Pharmacol; 1988 Aug; 37(16):3155-60. PubMed ID: 3401246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of quinidine on the dextromethorphan O-demethylase activity of microsomal fractions from human liver.
    Broly F; Libersa C; Lhermitte M; Bechtel P; Dupuis B
    Br J Clin Pharmacol; 1989 Jul; 28(1):29-36. PubMed ID: 2775613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Codeine O-demethylation: rat strain differences and the effects of inhibitors.
    Mikus G; Somogyi AA; Bochner F; Eichelbaum M
    Biochem Pharmacol; 1991 Mar; 41(5):757-62. PubMed ID: 1998530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism of dextromethorphan in human liver microsomes: a rapid HPCL assay to monitor cytochrome P450 2D6 activity.
    Vielnascher E; Spatzenegger M; Mayrhofer A; Klinger P; Jäger W
    Pharmazie; 1996 Aug; 51(8):586-8. PubMed ID: 8794469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of sodium ozagrel on the activity of rat CYP2D6.
    Wu H; Yu W; Huang L; Wang J; Tang X; Yang W; Liu Y; Yu H; Zhu D
    Eur J Pharmacol; 2007 Nov; 573(1-3):55-9. PubMed ID: 17651725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal methylation capacity in human liver cirrhosis.
    Geubel AP; Mairlot MC; Buchet JP; Dive C; Lauwerys R
    Int J Clin Pharmacol Res; 1988; 8(2):117-22. PubMed ID: 3378853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potent inhibition of cytochrome P-450 2D6-mediated dextromethorphan O-demethylation by terbinafine.
    Abdel-Rahman SM; Marcucci K; Boge T; Gotschall RR; Kearns GL; Leeder JS
    Drug Metab Dispos; 1999 Jul; 27(7):770-5. PubMed ID: 10383919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dextromethorphan to dextrorphan urinary metabolic ratio does not reflect dextromethorphan oral clearance.
    Borges S; Li L; Hamman MA; Jones DR; Hall SD; Gorski JC
    Drug Metab Dispos; 2005 Jul; 33(7):1052-5. PubMed ID: 15821042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of route of administration on dextromethorphan pharmacokinetics and behavioral response in the rat.
    Wu D; Otton SV; Kalow W; Sellers EM
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1431-7. PubMed ID: 7562518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expiratory measurement of maximal amino-pyrine demethylation in vivo: effect of phenobarbital, partial hepatectomy, protacaval shunt and bile duct ligation in the rat.
    Lauterburg BH; Bircher J
    J Pharmacol Exp Ther; 1976 Feb; 196(2):501-9. PubMed ID: 1255494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective effects of nitric oxide on the disposition of chlorzoxazone and dextromethorphan in isolated perfused rat livers.
    Vuppugalla R; Mehvar R
    Drug Metab Dispos; 2006 Jul; 34(7):1160-6. PubMed ID: 16621933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of biliary cirrhosis on the detoxification and elimination of a food derived carcinogen.
    Dietrich CG; Geier A; Wasmuth HE; Matern S; Gartung C; de Waart DR; Elferink RP
    Gut; 2004 Dec; 53(12):1850-5. PubMed ID: 15542527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of liver disease on dextromethorphan oxidation capacity and phenotype: a study in 107 patients.
    Larrey D; Babany G; Tinel M; Freneaux E; Amouyal G; Habersetzer F; Letteron P; Pessayre D
    Br J Clin Pharmacol; 1989 Sep; 28(3):297-304. PubMed ID: 2789923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential for CYP2D6 inhibition screening using a novel scintillation proximity assay-based approach.
    Delaporte E; Slaughter DE; Egan MA; Gatto GJ; Santos A; Shelley J; Price E; Howells L; Dean DC; Rodrigues AD
    J Biomol Screen; 2001 Aug; 6(4):225-31. PubMed ID: 11689122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dextromethorphan O-demethylation and dextrorphan glucuronidation in a French population.
    Duché JC; Quérol-Ferrer V; Barré J; Mésangeau M; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):392-8. PubMed ID: 8225685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-function relationship in secondary biliary cirrhosis in the rat. Stereologic and hemodynamic characterization of a model.
    Ohara N; Schaffner T; Reichen J
    J Hepatol; 1993 Feb; 17(2):155-62. PubMed ID: 8445230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamily.
    Gorski JC; Jones DR; Wrighton SA; Hall SD
    Biochem Pharmacol; 1994 Jul; 48(1):173-82. PubMed ID: 8043020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enzyme polymorphism on the metabolic O-demethylation of dextromethorphan in a South American population.
    Estévez F; Giusti M; Parrillo S; Oxandabarat J
    Medicina (B Aires); 1996; 56(4):378-82. PubMed ID: 9138342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.